---
title: "Inari Medical announces first patient enrolment in PEERLESS II randomised controlled trial"
date: "2023-11-28T18:39:40.000Z"
publishedDate: "28 novembre 2023"
summary: "Inari Medical has announced the first patient enrolment in PEERLESS II. This prospective, global, multicentre randomised controlled trial (RCT) compares the outcomes of intermediate-risk acute pulmonary embolism (PE) patients treated with the FlowTriever system against those treated with traditional anticoagulation therapy alone."
importance: ""
sourceUrl: "https://cardiovascularnews.com/inari-medical-announces-first-patient-enrolment-in-peerless-ii/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-11-28-inari-medical-announces-first-patient-enrolment-in-peerless-ii-randomised-controlled-trial"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/11/Flowtriever-Inari-Medical.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/inari-medical-announces-first-patient-enrolment-in-peerless-ii/"
---

![Inari Medical announces first patient enrolment in PEERLESS II randomised controlled trial](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/11/Flowtriever-Inari-Medical.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/inari-medical-announces-first-patient-enrolment-in-peerless-ii/*

## L’essentiel

Inari Medical has announced the first patient enrolment in PEERLESS II. This prospective, global, multicentre randomised controlled trial (RCT) compares the outcomes of intermediate-risk acute pulmonary embolism (PE) patients treated with the FlowTriever system against those treated with traditional anticoagulation therapy alone.

## Lien source

https://cardiovascularnews.com/inari-medical-announces-first-patient-enrolment-in-peerless-ii/
